165 related articles for article (PubMed ID: 11643443)
1. Universities can patent recombinant DNA results.
Dickson D
Nature; 1978 Mar; 272(5650):199. PubMed ID: 11643443
[No Abstract] [Full Text] [Related]
2. Genetic engineering and related biotechnologies: scientific progress and public policy.
Perpich JG
Technol Soc; 1983; 5(1):27-49. PubMed ID: 11650684
[No Abstract] [Full Text] [Related]
3. Report urges freedom for genetic engineers.
New Sci; 1981 Apr; 90(1247):8. PubMed ID: 11664138
[No Abstract] [Full Text] [Related]
4. Patenting biology: DNA and oil-eaters.
Sci News; 1978 Mar; 113(11):167+. PubMed ID: 11661560
[No Abstract] [Full Text] [Related]
5. The double helix of self-interest.
Simring FR
Sciences (New York); 1977; 17(3):10-13+. PubMed ID: 11661478
[No Abstract] [Full Text] [Related]
6. Recombinant DNA research; proposed actions under guidelines; notices.
U.S. National Institutes of Health
Fed Regist; 1988 Sep; 53(171):34246-7. PubMed ID: 11655893
[No Abstract] [Full Text] [Related]
7. Biotechnology: can a new technology survive?
Withers WW; Kenworthy PG
St Louis Univ Law J; 1987; 31(3):673-97. PubMed ID: 11650845
[No Abstract] [Full Text] [Related]
8. Corporate responsibility for recombinant DNA activities.
Berger BA
Univ Toledo Law Rev; 1981; 12(4):913-24. PubMed ID: 11649592
[No Abstract] [Full Text] [Related]
9. Recombinant DNA research; final plan for a program to assess the risks.
U.S. National Institutes of Health
Fed Regist; 1981 Jun; 46(111):30772-8. PubMed ID: 11655492
[No Abstract] [Full Text] [Related]
10. Government regulation of human gene therapy.
Gage JL
Jurimetrics; 1987; 27(2):200-18. PubMed ID: 11651978
[No Abstract] [Full Text] [Related]
11. Beyond Animal Legal Defense Fund v. Quigg: the controversy over transgenic animal patents continues.
Hecht EJ
Am Univ Law Rev; 1992; 41(3):1023-74. PubMed ID: 11652629
[No Abstract] [Full Text] [Related]
12. Recombinant DNA research: proposed actions under guidelines.
US National Institutes of Health
Fed Regist; 1984 Sep; 49(184):37016-7. PubMed ID: 11645519
[No Abstract] [Full Text] [Related]
13. Recombinant DNA and the regulation of biotechnology: reflections on the Asilomar Conference, ten years after.
Barkstrom JE
Akron Law Rev; 1985; 19(1):81-126. PubMed ID: 11650740
[No Abstract] [Full Text] [Related]
14. U.S. judge halts experiment in gene altering.
Hilts PJ
Washington Post; 1984 May; ():A1, A24. PubMed ID: 11646387
[No Abstract] [Full Text] [Related]
15. Recombinant DNA research; availability of environmental assessment for public comment; request for comments on need for a programmatic environmental impact statement; notice.
U.S. National Institutes of Health
Fed Regist; 1985 Apr; 50(72):14794-6. PubMed ID: 11645548
[No Abstract] [Full Text] [Related]
16. U.S. patent policy and biotechnology: growing pains on the cutting edge.
Cubert J
J Pat Trademark Off Soc; 1995 Feb; 77(2):151-74. PubMed ID: 11654243
[No Abstract] [Full Text] [Related]
17. Coordinated framework for regulation of biotechnology; establishment of the Biotechnology Science Coordinating Committee; notice.
U.S. Office of Science and Technology Policy
Fed Regist; 1985 Nov; 50(220):47174-95. PubMed ID: 11655733
[No Abstract] [Full Text] [Related]
18. Frost-free bacteria lawsuit.
Sci News; 1985 Mar; 127(9):135. PubMed ID: 11653601
[No Abstract] [Full Text] [Related]
19. A case analysis of NEPA implementation: NIH and DNA recombinant research.
Chalker SM; Catz RS
Duke Law J; 1978 Mar; 1978(1):57-112. PubMed ID: 11661621
[No Abstract] [Full Text] [Related]
20. Guidelines for research involving recombinant DNA molecules.
U.S. National Institutes of Health
Fed Regist; 1984 Nov; 49(227):46266-91. PubMed ID: 11655642
[No Abstract] [Full Text] [Related]
[Next] [New Search]
